What's happened
A high-profile trial examining puberty blockers for about 220 children aged 11‑16 is moving forward after a High Court judge rejects a last-minute challenge to delay the Pathways study. The court has found no realistic prospect of success for the bid, and recruitment is set to begin from August 1 under strict safeguards.
What's behind the headline?
What this means in practical terms
- The court has refused to pause the study, so recruitment will proceed as planned.
- The trial involves around 220 children and has been described as a pragmatic design with care for safety and ethical safeguards.
- Opponents remain vocal, citing long-term risks and dissenting voices from detransitioners and advocacy groups.
Who benefits and who bears the cost
- Clinicians argue the trial will provide needed evidence to guide NHS care for gender-dysphoric youth.
- Critics warn about potential harms and the adequacy of safeguards, urging caution and more robust evidence.
What’s next
- Recruitment starts on August 1; participants will be assessed over many months to determine potential clinical benefit.
How we got here
The Pathways trial, commissioned by NHS England and designed with input from multiple bodies, will study puberty suppression in young people with persistent gender incongruence. The judge emphasized careful assessment, assent from children, and informed consent from parents, with recruitment opening on 1 August.
Our analysis
The Guardian notes the High Court’s rejection of the bid to halt Pathways, with quotes from supporters and critics; Independent reports the judge’s summary and the HRA’s position; The Scotsman outlines the ongoing debate and public commentary around puberty blockers.
Go deeper
- What safeguards are in place for child participants?
- When will results be available to inform NHS policy?
- How are dissenting voices being considered in ongoing oversight?
More on these topics
-
Health Research Authority - Government department
The Health Research Authority is an executive non-departmental public body of the Department of Health in the United Kingdom. The HRA exists to provide a unified national system for the governance of health research.
-
British Broadcasting Corporation - Broadcasting company
The British Broadcasting Corporation is a British public service broadcaster. Headquartered at Broadcasting House in Westminster, London, it is the world's oldest national broadcaster, and the largest broadcaster in the world by number of employees.
-
Hilary Cass - Medical doctor
Hilary Dawn Cass OBE is a British medical doctor and a consultant in paediatric disability at St Thomas' Hospital, London. She was the President of the Royal College of Paediatrics and Child Health from 2012 to 2015.